Analysen von Eliana Merle
11.03.25 | BioNTech (ADRs) Neutral | UBS AG | |
02.10.24 | BioNTech (ADRs) Neutral | UBS AG | |
18.09.24 | BioNTech (ADRs) Neutral | UBS AG | |
10.05.24 | BioNTech (ADRs) Neutral | UBS AG | |
20.03.24 | BioNTech (ADRs) Neutral | UBS AG | |
09.01.24 | BioNTech (ADRs) Neutral | UBS AG | |
14.12.23 | BioNTech (ADRs) Neutral | UBS AG | |
28.11.23 | BioNTech (ADRs) Neutral | UBS AG | |
Werbung
|
|||
02.11.23 | Moderna Buy | UBS AG | |
23.10.23 | Moderna Buy | UBS AG | |
16.10.23 | BioNTech (ADRs) Neutral | UBS AG | |
06.06.23 | BioNTech (ADRs) Neutral | UBS AG | |
01.02.23 | BioNTech (ADRs) Neutral | UBS AG | |
19.01.23 | CureVac Buy | UBS AG | |
15.11.22 | BioNTech (ADRs) Neutral | UBS AG | |
30.06.22 | BioNTech (ADRs) Neutral | UBS AG | |
23.09.21 | BioNTech (ADRs) Neutral | UBS AG |